- Release Date: 15/05/25 08:24
- Summary: PAR Receives US Ethics Approval for Phase 3
- Price Sensitive: Yes
- Download Document 153.91KB
- Forums
- ASX - By Stock
- PAR
- Ann: PAR Receives US Ethics Approval for Phase 3
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
4.55%
!
31.5¢

Ann: PAR Receives US Ethics Approval for Phase 3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.5¢ |
Change
-0.015(4.55%) |
Mkt cap ! $128.1M |
Open | High | Low | Value | Volume |
33.5¢ | 33.5¢ | 31.5¢ | $203.3K | 628.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 49712 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 46893 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 56119 | 0.315 |
10 | 78768 | 0.310 |
9 | 148549 | 0.305 |
18 | 188088 | 0.300 |
4 | 72272 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 21328 | 2 |
0.325 | 40701 | 6 |
0.330 | 53726 | 7 |
0.335 | 12734 | 5 |
0.340 | 66200 | 5 |
Last trade - 11.17am 08/08/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |